Novavax Inc (NVAX)
15.50
+0.35
(+2.31%)
USD |
NASDAQ |
May 24, 16:00
15.42
-0.08
(-0.52%)
After-Hours: 20:00
Novavax SG&A Expense (TTM): 443.21M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 443.21M |
December 31, 2023 | 468.95M |
September 30, 2023 | 475.37M |
June 30, 2023 | 490.79M |
March 31, 2023 | 505.23M |
December 31, 2022 | 488.69M |
September 30, 2022 | 411.24M |
June 30, 2022 | 366.16M |
March 31, 2022 | 331.16M |
December 31, 2021 | 298.36M |
September 30, 2021 | 275.46M |
June 30, 2021 | 254.54M |
March 31, 2021 | 199.10M |
December 31, 2020 | 145.29M |
September 30, 2020 | 92.16M |
June 30, 2020 | 43.18M |
March 31, 2020 | 35.06M |
December 31, 2019 | 34.42M |
September 30, 2019 | 35.46M |
June 30, 2019 | 35.87M |
March 31, 2019 | 34.49M |
December 31, 2018 | 34.41M |
September 30, 2018 | 33.72M |
June 30, 2018 | 33.53M |
March 31, 2018 | 34.25M |
Date | Value |
---|---|
December 31, 2017 | 34.45M |
September 30, 2017 | 34.25M |
June 30, 2017 | 39.69M |
March 31, 2017 | 44.85M |
December 31, 2016 | 46.53M |
September 30, 2016 | 47.03M |
June 30, 2016 | 42.54M |
March 31, 2016 | 35.53M |
December 31, 2015 | 30.84M |
September 30, 2015 | 27.05M |
June 30, 2015 | 22.74M |
March 31, 2015 | 21.46M |
December 31, 2014 | 19.93M |
September 30, 2014 | 18.95M |
June 30, 2014 | 18.05M |
March 31, 2014 | 16.26M |
December 31, 2013 | 14.82M |
September 30, 2013 | 13.21M |
June 30, 2013 | 11.49M |
March 31, 2013 | 9.945M |
December 31, 2012 | 10.06M |
September 30, 2012 | 9.562M |
June 30, 2012 | 10.16M |
March 31, 2012 | 11.03M |
December 31, 2011 | 10.90M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
34.42M
Minimum
Dec 2019
505.23M
Maximum
Mar 2023
271.48M
Average
286.91M
Median
SG&A Expense (TTM) Benchmarks
Pfizer Inc | 14.85B |
Moderna Inc | 1.518B |
Vaxart Inc | 23.20M |
Sensus Healthcare Inc | 10.15M |
Agilent Technologies Inc | 1.611B |